[Federal Register Volume 85, Number 82 (Tuesday, April 28, 2020)]
[Notices]
[Pages 23602-23603]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09002]


=======================================================================
-----------------------------------------------------------------------

U.S.-CHINA ECONOMIC AND SECURITY REVIEW COMMISSION


Notice of Open Public Hearing

AGENCY: U.S.-China Economic and Security Review Commission.

ACTION: Notice of open public hearing.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given of the following hearing of the U.S.-
China Economic and Security Review Commission.
    The Commission is mandated by Congress to investigate, assess, and 
report to Congress annually on ``the national security implications of 
the economic relationship between the United States and the People's 
Republic of China.'' Pursuant to this mandate, the Commission will hold 
a virtual public hearing in Washington, DC on May 7, 2020 on ``China's 
Evolving Healthcare Ecosystem: Challenges and Opportunities.''

DATES: The hearing is scheduled for Thursday, May 7, 2020, at 9:30 a.m.

ADDRESSES: This hearing will be held online, with panelists and 
Commissioners participating via videoconference. Members of the public 
will be able to view a live webcast via the Commission's website at 
www.uscc.gov. Please check the Commission's website for possible

[[Page 23603]]

changes to the hearing schedule. Reservations are not required to 
attend the hearing.

FOR FURTHER INFORMATION CONTACT: Any member of the public seeking 
further information concerning the hearing should contact Jameson 
Cunningham, 444 North Capitol Street NW, Suite 602, Washington, DC 
20001; telephone: 202-624-1496, or via email at jcunningham@uscc.gov. 
Reservations are not required to attend the hearing.
    ADA Accessibility: For questions about the accessibility of the 
event or to request an accommodation, please contact Jameson Cunningham 
at 202-624-1496, or via email at jcunningham@uscc.gov. Requests for an 
accommodation should be made as soon as possible, and at least five 
business days prior to the event.

SUPPLEMENTARY INFORMATION: 
    Background: This hearing will examine new developments in China's 
healthcare system, the challenges these pose to continued U.S. 
leadership in the medical sciences, as well as the opportunities they 
potentially create for U.S. researchers and companies. The first panel 
reviews China's domestic healthcare infrastructure, Beijing's ambitions 
for digital healthcare technologies, and China's public health 
emergency preparedness both before and after the emergence of the 
COVID-19 pandemic. The second panel will investigate linkages between 
the United States and Chinese healthcare ecosystems, with a particular 
emphasis on market access and data sharing, technological competition, 
and the benefits and risks of research cooperation.
    The hearing will be co-chaired by Chairman Robin Cleveland and 
Commissioner Thea Lee. Any interested party may file a written 
statement by May 7, 2020 by transmitting to the contact above. A 
portion of the hearing will include a question and answer period 
between the Commissioners and the witnesses.
    Authority: Congress created the U.S.-China Economic and Security 
Review Commission in 2000 in the National Defense Authorization Act 
(Pub. L. 106-398), as amended by Division P of the Consolidated 
Appropriations Resolution, 2003 (Pub. L. 108-7), as amended by Public 
Law 109-108 (November 22, 2005), as amended by Public Law 113-291 
(December 19, 2014).

    Dated: April 23, 2020.
Daniel W. Peck,
Executive Director, U.S.-China Economic and Security Review Commission.
[FR Doc. 2020-09002 Filed 4-27-20; 8:45 am]
 BILLING CODE 1137-00-P